Back to Trials
NCT06001827NARecruiting

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

VenoStent

Start Date

1/3/2024

Completion Date

12/1/2029

Summary

This is a prospective, randomized, multi-center clinical trial for chronic kidney disease (CKD) patients referred for creation of a new arteriovenous fistula (AVF) in order to assess the safety and effectiveness of SelfWrap, a bioabsorbable perivascular wrap.

Detailed Description

This is a multi-center, prospective, randomized, double-arm, single-blind, evaluator-blinded clinical trial for CKD patients referred for creation of a new arteriovenous fistula (AVF). This study will involve approximately 600 participants from up to 30 investigational sites, randomized 1:1 to treatment with the SelfWrap or the untreated AVF control (i.e. standard of care, SOC). Participants will be followed for a duration of 36 months.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Age of at least 18 years * Referred for creation of a new AVF * Willing and able to comply with study requirements, communicate with the study team, and attend follow up visits over a period of 36 months Exclusion Criteria: * Planned index procedure to revise or repair an existing fistula * Target artery inner diameter \< 2.0 mm, as measured by ultrasound while the target arm is under tourniquet pressure and anesthesia * Target vein inner diameter \< 2.0 mm, as measured by ultrasound while the target arm is under tourniquet pressure and anesthesia * Significant (at least 50%) stenosis at the target vein on the side of surgery (between the planned anastomosis site and the axillary vein), as diagnosed by preoperative ultrasound * Known central venous stenosis of at least 50% on the side of surgery * Presence of a stent or a stent graft within the access circuit * Known or suspected coagulation disorder that, in the opinion of the Investigator, puts too much risk on the patient for AVF creation * Known or suspected active infection at the time of surgery * Congestive heart failure NYHA class 4 * Prior steal on the side of surgery; * Enrolled in another investigational drug, device, or biological study, or was previously enrolled in this study * Life expectancy less than 12 months * Expected to undergo kidney transplant surgery within 6 months of enrollment * Expected to undergo home hemodialysis * Females of childbearing potential (premenopausal and not surgically sterile) without documented current negative pregnancy test at screening * Presence of a comorbid condition that, in the opinion of the Investigator, may significantly confound the collection of safety and efficacy data in this study * Unwillingness or inability to give consent and/or comply with the study follow up schedule * Any health condition, which in the opinion of the Investigator, would interfere with the safety of the participant or the participant's ability to comply with the study.

Interventions

DEVICE

SelfWrap Bioabsorbable Perivascular Wrap

PROCEDURE

Untreated AVF Control

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Chronic Kidney DiseasesEnd Stage Renal DiseaseArteriovenous FistulaHemodialysis Access FailureESRDVascular Access ComplicationRenal FailureCatheter ComplicationsCatheter DysfunctionRenal Insufficiency

Locations

AKDHC Bullhead City

Bullhead City, Arizona 86442

United States

AKDHC Marana Surgery Center

Marana, Arizona 85658

United States

Arizona Kidney Disease & Hypertension Centers (AKDHC) Phoenix Surgery Center

Phoenix, Arizona 85012

United States

Banner University Medical Center

Tucson, Arizona 85724

United States

Orange County Vascular Access Center

Garden Grove, California 92840

United States

Tallahassee Research Institute

Tallahassee, Florida 32308

United States

Lutheran Medical Group

Fort Wayne, Indiana 46804

United States

Surgical Associates of Lexington

Lexington, Kentucky 40503

United States

Brigham and Women's Hospital

Boston, Massachusetts 02115

United States

Mayo Clinic

Rochester, Minnesota 55905

United States

University of Missouri

Columbia, Missouri 65212

United States

Saint Louis University

St Louis, Missouri 63104

United States

Washington University School of Medicine

St Louis, Missouri 63110

United States

Northwell Health

Lake Success, New York 11042

United States

Surgical Specialists of Charlotte, P.A.

Charlotte, North Carolina 28226

United States

WakeMed

Raleigh, North Carolina 27610

United States

MUSC Charleston

Charleston, South Carolina 29425

United States

Vascular Care of South Carolina

Columbia, South Carolina 29203

United States

MUSC Black River

Florence, South Carolina 29505

United States

Prisma Health

Greenville, South Carolina 29615

United States

Medical University of South Carolina (MUSC) Orangeburg / Dialysis Access Institute

Orangeburg, South Carolina 29118

United States

Spartanburg Regional Medical Center

Spartanburg, South Carolina 29650

United States

James Eric Gardner, MD, PC

Memphis, Tennessee 38115

United States

Saint David's HealthCare Partnership, L.P., LLP

Austin, Texas 78701

United States

A&V Doctors PLLC

El Paso, Texas 79912

United States

Houston Methodist Research Institute

Houston, Texas 77030

United States

Upper Valley Dialysis Access Center, LLC

Mission, Texas 78572

United States

Houston Methodist Research Institute (Sugar Land)

Sugar Land, Texas 77479

United States